JUN and breast cancer: In summary, this study identified JUN, NFKB1, and SP1 as important biomarkers associated with stem cells and telomere maintenance mechanisms in BC, highlighting their critical roles in tumor progression, alterations in the immune microenvironment, and potential therapeutic targets.